|
|
|
|
|
-
Tuesday, July 29, 2025
12:33:45 PM HKT
|
|
|
| Press Releases |
|
 |
|
| Monday, February 24, 2025 |
|
|
"Hong Kong Holiday & Travel Expo 2025" Successfully Concludes |
| The "Hong Kong Holiday & Travel Expo 2025," a premier travel carnival, concluded today with resounding success, which marks a significant 27% increase in attendance compared to the expo last year. The exhibition hall was abuzz with activity, and exhibitors reported robust business performance, underscoring the public's unwavering enthusiasm for travel products and experiences. more info >> |
|
| Tuesday, February 25, 2025 |
|
|
旅遊嘉年華「香港旅遊博覽會2025」圓滿落幕 |
| 旅遊嘉年華「香港旅遊博覽會2025」於今日圓滿結束，為期四天的展期入場人數再創新高，較去年的博覽會增加27%。展場內人潮湧動，參展商生意興隆，充分展現市民對旅遊產品的持續熱情與需求。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇樹衝刺IPO、機械人應用加速落地：首程控股雙輪驅動兌現紅利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇树冲刺IPO、机器人应用加速落地：首程控股双轮驱动兑现红利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
國泰君安國際連續第三年實現營運層面「碳中和」
Jul 29, 2025 11:19 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 9:01 JST
|
|
|
GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 05:00: JST
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT/SGT
|
|
|
HKTDC boosts Hong Kong's competitive edge in high-value services
Jul 28, 2025 23:30 HKT/SGT
|
|
|
Intelligent Tech Unlocks the Future - Connecting the World, CITIC Telecom Unveils Future-ready Solutions at WAIC 2025
Jul 28, 2025 23:16 HKT/SGT
|
|
|
Phoenitron Grants Share Options and Sets HK$75 Million Profit Target for First Three Quarters
Jul 28, 2025 23:08 HKT/SGT
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 28, 2025 21:00: JST
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 28, 2025 20:00 HKT/SGT
|
|
|
KKR、トプコンに対する公開買付けを開始
Jul 28, 2025 19:30: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
| Copyright © 2025 ACN Newswire - Asia Corporate News Network |
|
|
|
|
| |
